Company · founded 2006

VPDiagnostics (United States)

Seattle, United States · vpdiagnostics.com

Manage this page

Citations, last 5 years: 0
Works, last 5 years: 2
h-index: 6
Scientists listed: 1
Grants since 2016: 24

Grants received

2024–2025 · research · R42

Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis

Michael B Fallon · VPDiagnostics (United States) · funded by National Institutes of Health

$326kCell Adhesion Molecules Research

2024–2028 · research · R42

Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis

Michael B Fallon · VPDiagnostics (United States) · funded by National Institutes of Health

$663.8k

2023–2025 · contract · N44

NCI SBIR Contract Topic 428 Phase II (Solicitation Number: BAA 75N91022R00027): Cloud-based Liquid-biopsy and Radiomics Platform for the Cancer Research Data Commons

Chun-Chi Liu · VPDiagnostics (United States) · funded by National Institutes of Health

$2M

2022–2024 · research · R41

Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis

Kenneth S Knox · VPDiagnostics (United States) · funded by National Institutes of Health

$299.9kInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

2022–2027 · research · R42

Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis

Kenneth S Knox · VPDiagnostics (United States) · funded by National Institutes of Health

$673.8kInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

2022–2024 · research · R41

Leveraging platelet signal transduction for personalized antiplatelet therapy

David Barrios · VPDiagnostics (United States) · funded by National Institutes of Health

$259.6kAntiplatelet Therapy and Cardiovascular Diseases

2022–2027 · research · R42

Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis

Kenneth S Knox · VPDiagnostics (United States) · funded by National Institutes of Health

$663.3k

2021–2022 · contract · N43

TOPIC 428 "CLOUD-BASED LIQUID-BIOPSY PLATFORM FOR THE CANCER RESEARCH DATA COMMONS"

Chun-Chi Liu · VPDiagnostics (United States) · funded by National Institutes of Health

$395.9k

2021–2023 · research · R44

A Rapid Multiplexed Assay for the Diagnosis of Viral Hepatitis at the Point of Care

Johann Desa · VPDiagnostics (United States) · funded by Centers for Disease Control and Prevention

$464.1k

2021–2023 · research · R44

A Rapid Multiplexed Assay for the Diagnosis of Viral Hepatitis at the Point of Care

Johann Desa · VPDiagnostics (United States) · funded by Centers for Disease Control and Prevention

$572.9k

2021–2025 · research · R21

Device for Preservation of Cell Free RNA in Saliva

Shivani Nautiyal · VPDiagnostics (United States) · funded by National Institutes of Health

$218.2kSalivary Gland Disorders and Functions

2020–2026 · grant · PRMRP

A Portable Point-of-Care Diagnostic Device for the Rapid Screening of Hepatitis B

Johann Desa · VPDiagnostics (United States) · funded by Congressionally Directed Medical Research Programs

$4.1M

2020–2021 · research · R43

An Accurate, Non-invasive, and Cost-effective Methylome Test for Early Cancer Detection

Xiaohui Ni · VPDiagnostics (United States) · funded by National Institutes of Health

$351.6k

2020–2024 · research · R44

MethylScan for Early Detection of Liver and Lung Cancer

Steven-Huy B Han · VPDiagnostics (United States) · funded by National Institutes of Health

$997.3k

2020–2021 · research · R43

A Rapid Multiplexed Test for the Screening of Sepsis and Organ Dysfunction at the Point of Care

Johann Desa · VPDiagnostics (United States) · funded by National Institutes of Health

$225kSepsis Diagnosis and Treatment

2020–2025 · research · R44

MethylScan for Early Detection of Liver and Lung Cancer

Steven-Huy B Han · VPDiagnostics (United States) · funded by National Institutes of Health

$997.3k

2019–2024 · research · R42

Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma

Timothy A Marlowe · VPDiagnostics (United States) · funded by National Institutes of Health

$674.5kCell Adhesion Molecules Research

2019–2021 · research · R41

Discovery of Novel Peptidic Inhibitors of the Non-Catalytic Function of Focal Adhesion Kinase (FAK)

William G Cance · VPDiagnostics (United States) · funded by National Institutes of Health

$289.6kCell Adhesion Molecules Research

2019–2025 · research · R42

Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma

Timothy A Marlowe · VPDiagnostics (United States) · funded by National Institutes of Health

$654.7kCell Adhesion Molecules Research

2019–2024 · research · R42

Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma

Timothy A Marlowe · VPDiagnostics (United States) · funded by National Institutes of Health

$670.8kCell Adhesion Molecules Research

2018–2019 · research · R43

A Rapid Multiplexed Assay for the Diagnosis of Viral Hepatitis at the Point of Care

Johann Desa · VPDiagnostics (United States) · funded by Centers for Disease Control and Prevention

$150k

2018–2021 · contract · N44

SARS-CoV-2 DISEASE SURVEILLANCE

Kellie Honug Zhu · VPDiagnostics (United States) · funded by National Institutes of Health

$937.5k

2017–2020 · grant · Standard Grant

SBIR Phase II: Development of a Rapid, Point-Of-Care, Diagnostic Technology Platform with the Diagnosis of Liver Cancer as the First Application

Johann Desa · VPDiagnostics (United States) · funded by National Science Foundation

$888.1k

2016–2017 · grant · Standard Grant

SBIR Phase I: Development of a Rapid, Point-Of-Care, Diagnostic Technology Platform with the Diagnosis of Liver Cancer as the First Application

Johann Desa · VPDiagnostics (United States) · funded by National Science Foundation

$225kBiosensors and Analytical Detection